Non-Hodgkin's Lymphoma News & Updates
FDA OKs Triple Combo for Advanced Large B-Cell Lymphoma
- FDA Approves New Drug Combination for Mantle Cell Lymphoma
February 5, 2025 — The FDA has approved a new pill to treat adults with a type of blood cancer called mantle cell lymphoma (MCL).
- FDA Approves New Prep Regimen for Bone Marrow Transplant
January 23, 2025 — The FDA has approved a new treatment, Grafapex, to help people get ready for a bone marrow transplant.
- First-in-Class Leukemia Treatment Approved by FDA
November 19, 2024 — The FDA has approved a new drug called revumenib that can be taken orally to treat acute leukemia in patients 1 year or older. The drug will be marketed under the brand name Revuforj.
- FDA Fast-Tracks Asciminib for New Chronic Leukemia Patients
October 31, 2024 — The FDA has granted accelerated approval to asciminib as a first-line treatment for adults newly diagnosed with Philadelphia chromosome–positive chronic myeloid leukemia, a rare type of blood cancer.
- CAR T Cancer Therapy Can Be Lifesaving – if You Can Afford It
June 22, 2023 — CAR T cells are a relatively new but dynamic treatment for blood cancers, but the price of the drugs and access to care put them out of reach for some patients who need them.
